A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

@article{Carlson2007APS,
  title={A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder},
  author={Gabrielle A. Carlson and David W. Dunn and Douglas K. Kelsey and Dustin D Ruff and Susan G. Ball and Lisa M Ahrbecker and Albert J. Allen},
  journal={Child and Adolescent Psychiatry and Mental Health},
  year={2007},
  volume={1},
  pages={10 - 10}
}
BACKGROUND This study examined augmenting atomoxetine with extended-release methylphenidate in children whose attention-deficit/hyperactivity disorder (ADHD) previously failed to respond adequately to stimulant medication. METHODS Children with ADHD and prior stimulant treatment (N = 25) received atomoxetine (1.2 mg/kg/day) plus placebo. After 4 weeks, patients who were responders (n = 4) were continued on atomoxetine/placebo while remaining patients were randomly assigned to either… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Atomoxetine and psychostimulants for ADHD: Is there differential response? Oral presentation given at the American Academy Child and Adolescent Psychiatry national conference

J Newcorn
2004
View 1 Excerpt

Concomitant psychotropic medication for youths.

The American journal of psychiatry • 2003
View 1 Excerpt

ADHD Rating ScaleIV: Checklists, Norms, and Clinical Impressions New The Guildford

GJ DuPaul, TJ Power, AD Anastopoulos, R Reid
1998
View 1 Excerpt

Similar Papers

Loading similar papers…